Does reducing Grb2 alter aging?
Does reducing Grb2 alter aging?
批准号:
7244068
负责人:
FENG LIU
金额:
$17.44万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2008-05-31
关键词:
Adaptor Signaling ProteinAgeAgingAnimal ModelAnimalsAttenuatedBindingBiologicalBreast CarcinomaCaloric RestrictionDataDevelopmentDisruptionEventFigs - dietaryGene ExpressionGene TargetingIncidenceInsulinInsulin-Like-Growth Factor I ReceptorLongevityMediatingMitogen-Activated Protein KinasesMolecularMusOxidative StressPathologyPlayPolyomaviruses Middle T ProteinsProtein IsoformsResistanceRoleSignal PathwaySignaling MoleculeTestingbasenovelp66(ShcA) proteinprotein functiontumortumor progression
中文摘要
描述(由申请人提供):Grb2是一种受体蛋白,在胰岛素和IGF-I受体下游起作用。Grb2结合到She异构体上,在胰岛素/ igf - 1介导的有丝分裂事件中起关键作用。一些数据表明,降低Grb2表达水平可能会减缓衰老相关肿瘤的进展,延长寿命。首先,Grb2的表达增强加速了肿瘤的发展。相反,通过基因靶向降低Grb2表达可延缓多瘤病毒中T抗原诱导的全动物乳腺癌。此外,与Grb2相互作用的She亚型之一p66Shc的基因表达被破坏,导致抗氧化应激能力增强,寿命延长。最后,热量限制显著降低了Grb2的表达水平,这已经被证实可以延长最长寿命,同时减缓与年龄相关的病理(如肿瘤进展)的发展。基于这些发现,我们假设降低小鼠中Grb2的表达水平可以通过延缓肿瘤进展和增强对氧化应激的抵抗力来延长寿命。为了验证这一假设,我们提出以下具体目标:探讨降低Grb2表达是否能增强小鼠抗氧化应激能力。2. 确定降低Grb2表达水平是否能抑制小鼠肿瘤的发生。3. 确定降低小鼠Grb2表达是否会延长寿命。这些研究的结果将使我们能够确定Grb2表达水平降低的小鼠是否是研究衰老的新动物模型。
英文摘要
DESCRIPTION (provided by applicant): Grb2 is an adaptor protein that functions downstream of the insulin and IGF-I receptors. Grb2 binds to the She isoforms and plays a key role in insulin/IGF-l-mediated mitogenic events. There are some data suggesting that reducing Grb2 expression levels may decrease aging-associated tumor progression and extend lifespan. First, enhanced expression of Grb2 accelerates tumor development. In contrast, reducing Grb2 expression by gene targeting retards mammary carcinomas induced by polyomavirus middle T antigen in whole animals. Furthermore, disruption of the gene expression of p66Shc, one of the She isoforms that interacts with Grb2, leads to increased resistance to oxidative stress and extended lifespan. Finally, caloric restriction, which has been conclusively and reproducibly shown to increase maximum lifespan while attenuating the development of age-associated pathology such as tumor progression, significantly reduced the expression levels of Grb2. Based on these findings, we hypothesize that reducing the expression levels of Grb2 in mice increases lifespan by delaying tumor progression and increasing resistance to oxidative stress. To test this hypothesis, we propose the following Specific Aims: 1. To determine whether reducing Grb2 expression enhances resistance to oxidative stress in mice. 2. To determine whether reducing Grb2 expression levels inhibits tumor incidence in mice. 3. To determine whether reducing Grb2 expression in mice leads to extended lifespan. Results from these studies will allow us to determine if the mice with reduced levels of Grb2 expression are a novel animal model to study aging.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Regulation of Adipose Tissue Function by Grb10
-
批准号:8884599
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:FENG LIU
-
依托单位:
Regulation of Adipose Tissue Function by Grb10
-
批准号:9095352
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:FENG LIU
-
依托单位:
Regulation of Adipose Tissue Function by Grb10
-
批准号:8612836
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:FENG LIU
-
依托单位:
Regulation of Adipose Tissue Function by Grb10
-
批准号:8733684
-
项目类别:
-
资助金额:$37.38万
-
财政年份:2013
-
负责人:FENG LIU
-
依托单位:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
-
批准号:8321471
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:FENG LIU
-
依托单位:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
-
批准号:8493793
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2011
-
负责人:FENG LIU
-
依托单位:
Nanocrystals for the Treatment of Multidrug Resistance in Cancer
-
批准号:8038042
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2011
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:7997090
-
项目类别:
-
资助金额:$9.9万
-
财政年份:2009
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:7585784
-
项目类别:
-
资助金额:$29.94万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:8827760
-
项目类别:
-
资助金额:$33.46万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:8697171
-
项目类别:
-
资助金额:$33.85万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:8037571
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:8212437
-
项目类别:
-
资助金额:$29.4万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Regulation and Function of Adiponectin Oligomerization
-
批准号:9037002
-
项目类别:
-
资助金额:$33.03万
-
财政年份:2008
-
负责人:FENG LIU
-
依托单位:
Does reducing Grb2 alter aging?
-
批准号:7037694
-
项目类别:
-
资助金额:$14.97万
-
财政年份:2006
-
负责人:FENG LIU
-
依托单位:
Non-Viral Vectors for Liver Gene Transfer
-
批准号:6818976
-
项目类别:
-
资助金额:$10.15万
-
财政年份:2004
-
负责人:FENG LIU
-
依托单位:
Neuronal Insulin Signaling and Aging
-
批准号:6947047
-
项目类别:
-
资助金额:$29.57万
-
财政年份:2004
-
负责人:FENG LIU
-
依托单位:
Non-Viral Vectors for Liver Gene Transfer
-
批准号:7213946
-
项目类别:
-
资助金额:$10.38万
-
财政年份:2004
-
负责人:FENG LIU
-
依托单位:
Non-Viral Vectors for Liver Gene Transfer
-
批准号:6911664
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2004
-
负责人:FENG LIU
-
依托单位:
Neuronal Insulin Signaling and Aging
-
批准号:7102598
-
项目类别:
-
资助金额:$28.87万
-
财政年份:2004
-
负责人:FENG LIU
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: